Eric D. Shaff - 04 Feb 2022 Form 4 Insider Report for Seres Therapeutics, Inc. (MCRB)

Role
President, CEO, Director
Signature
/s/ Thomas J. DesRosier, attorney-in-fact for Eric D. Shaff
Issuer symbol
MCRB
Transactions as of
04 Feb 2022
Net transactions value
$0
Form type
4
Filing time
08 Feb 2022, 20:30:35 UTC
Previous filing
28 Jun 2021
Next filing
27 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MCRB Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 04 Feb 2022 Common Stock 500,000 $7.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 25% of the shares on February 4, 2023. The remainder of the shares will vest in 12 equal quarterly installments thereafter.